Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency

Journal of Cardiac Failure

Volumn 20, Issue 4, 2014, Pages 268-277

  Suzuki, Tomoyasu ^a   Hanawa, Haruo ^a   Jiao, Shuang ^a   Ohno, Yukako ^a   Hayashi, Yuka ^a   Yoshida, Kaori ^a   Kashimura, Takeshi ^a   Obata, Hiroaki ^a   Minamino, Tohru ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

bone morphogenetic protein; cytokine; Heart failure; Toll like receptor 4

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; HEME; HEMOGLOBIN; HEMOSIDERIN; HEPCIDIN; INTERLEUKIN 6; IRON; PHENYLHYDRAZINE; TOLL LIKE RECEPTOR 4; TRANSFERRIN; RNA;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BONE MARROW; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART FAILURE; HEMOLYTIC ANEMIA; HISTOLOGY; INFERIOR CAVA VEIN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; LEWIS RAT; LIVER CELL; LIVER CONGESTION; NONHUMAN; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN; VEIN LIGATION; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DEFICIENCY; DISEASE MODEL; ELECTRON PROBE MICROANALYSIS; GENETICS; IMMUNOHISTOCHEMISTRY; IRON DEFICIENCY ANEMIA; KNOCKOUT MOUSE; LIVER; LIVER DISEASE; METABOLISM; MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANEMIA, IRON-DEFICIENCY; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTRON PROBE MICROANALYSIS; HEPCIDINS; IMMUNOHISTOCHEMISTRY; IRON; LIVER; LIVER DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, INBRED LEW; REAL-TIME POLYMERASE CHAIN REACTION; RNA;

EID: 84897469013     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.01.008     Document Type: Article

References (60)

1. J.A. Ezekowitz, F.A. McAlister, and P.W. Armstrong Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure Circulation 107 2003 223 225 (Pubitemid 36135214)
2. J.K. Ghali Anemia and heart failure Curr Opin Cardiol 24 2009 172 178
3. B.D. Westenbrink, F.W. Visser, A.A. Voors, T.D. Smilde, E. Lipsic, and G. Navis et al. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well Eur Heart J 28 2007 166 171
4. A.S. Androne, S.D. Katz, L. Lund, J. LaManca, A. Hudaihed, and K. Hryniewicz et al. Hemodilution is common in patients with advanced heart failure Circulation 107 2003 226 229 (Pubitemid 36135215)
5. C. Adlbrecht, S. Kommata, M. Hulsmann, T. Szekeres, C. Bieglmayer, and G. Strunk et al. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume Eur Heart J 29 2008 2343 2350
6. G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 2005 1011 1023
7. J.W. Eschbach Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness J Am Soc Nephrol 13 2002 1412 1414 (Pubitemid 34441425)
8. C. Kliger, R. Eiros, G. Isasti, B. Einhorn, V. Jelnin, and H. Cohen et al. Review of surgical prosthetic paravalvular leaks: diagnosis and catheter-based closure Eur Heart J 34 2013 638 649
9. T. Kubo, H. Kitaoka, Y. Terauchi, S. Tamura, M. Okawa, and N. Yamasaki et al. Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy J Cardiol 55 2010 125 129
10. G. Holleran, B. Hall, M. Hussey, and D. McNamara Small bowel angiodysplasia and novel disease associations: a cohort study Scand J Gastroenterol 48 2013 433 438
11. B.D. Westenbrink, A.A. Voors, R.A. de Boer, J.J. Schuringa, T. Klinkenberg, and P. van der Harst et al. Bone marrow dysfunction in chronic heart failure patients Eur J Heart Fail 12 2010 676 684
12. C.K. Kissel, R. Lehmann, B. Assmus, A. Aicher, J. Honold, and U. Fischer-Rasokat et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure J Am Coll Cardiol 49 2007 2341 2349 (Pubitemid 46891715)
13. P. van der Meer, D.J. Lok, J.L. Januzzi, P.W. de la Porte, E. Lipsic, and J. van Wijngaarden et al. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients Eur Heart J 29 2008 1510 1515 (Pubitemid 351881986)
14. K.K. Witte, R. Desilva, S. Chattopadhyay, J. Ghosh, J.G. Cleland, and A.L. Clark Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 147 2004 924 930 (Pubitemid 38881010)
15. C. Opasich, M. Cazzola, L. Scelsi, S. de Feo, E. Bosimini, and R. Lagioia et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure Eur Heart J 26 2005 2232 2237 (Pubitemid 41541385)
16. J.N. Nanas, C. Matsouka, D. Karageorgopoulos, A. Leonti, E. Tsolakis, and S.G. Drakos et al. Etiology of anemia in patients with advanced heart failure J Am Coll Cardiol 48 2006 2485 2489 (Pubitemid 44881220)
17. D.O. Okonko, A.K. Mandal, C.G. Missouris, and P.A. Poole-Wilson Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival J Am Coll Cardiol 58 2011 1241 1251
18. E.A. Jankowska, P. Rozentryt, A. Witkowska, J. Nowak, O. Hartmann, and B. Ponikowska et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur Heart J 31 2010 1872 1880
19. D.J. van Veldhuisen, S.D. Anker, P. Ponikowski, and I.C. Macdougall Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches Nat Rev Cardiol 8 2011 485 493
20. I.C. Macdougall, B. Canaud, A.L. de Francisco, G. Filippatos, P. Ponikowski, and D. Silverberg et al. Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency Eur J Heart Fail 14 2012 882 886
21. S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, and H. Drexler et al. Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
22. S.D. Anker, J.C. Colet, G. Filippatos, R. Willenheimer, K. Dickstein, and H. Drexler et al. Rationale and design of Ferinject Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia Eur J Heart Fail 11 2009 1084 1091
23. T. Ganz Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 102 2003 783 788 (Pubitemid 36917762)
24. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, and D.M. Ward et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093 (Pubitemid 40007660)
25. E. Nemeth, E.V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 101 2003 2461 2463 (Pubitemid 36857598)
26. G. Nicolas, M. Bennoun, A. Porteu, S. Mativet, C. Beaumont, and B. Grandchamp et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin Proc Natl Acad Sci U S A 99 2002 4596 4601 (Pubitemid 34286030)
27. T. Ganz Hepcidin and iron regulation, 10 years later Blood 117 2011 4425 4433
28. G. Nicolas, C. Chauvet, L. Viatte, J.L. Danan, X. Bigard, and I. Devaux et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation J Clin Invest 110 2002 1037 1044
29. L. Lin, E.V. Valore, E. Nemeth, J.B. Goodnough, V. Gabayan, and T. Ganz Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4 Blood 110 2007 2182 2189 (Pubitemid 47443938)
30. T. Ganz, and E. Nemeth The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders Hematology Am Soc Hematol Educ Program 2011 2011 538 542
31. M. Matsumoto, T. Tsujino, M. Lee-Kawabata, Y. Naito, H. Akahori, and T. Sakoda et al. Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia Circ J 74 2010 301 306
32. E.A. Jankowska, J. Malyszko, H. Ardehali, E. Koc-Zorawska, W. Banasiak, and S. von Haehling et al. Iron status in patients with chronic heart failure Eur Heart J 34 2013 827 834
33. C.H. Park, E.V. Valore, A.J. Waring, and T. Ganz Hepcidin, a urinary antimicrobial peptide synthesized in the liver J Biol Chem 276 2001 7806 7810
34. M. Isoda, H. Hanawa, R. Watanabe, T. Yoshida, K. Toba, and K. Yoshida et al. Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction J Nutr Biochem 21 2010 749 756
35. J.M. Arcidi Jr., G.W. Moore, and G.M. Hutchins Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy Am J Pathol 104 1981 159 166 (Pubitemid 11052586)
36. T. Suzuki, H. Hanawa, L. Ding, M. Ito, T. Kashimura, and H. Obata et al. Improvement of anemia with decreasing hepcidin levels following valve replacement for severe tricuspid regurgitation Eur J Haematol 88 2012 551 552
37. R. Babu, J.H. Bagley, C. Di, A.H. Friedman, and C. Adamson Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention Neurosurg Focus 32 2012 E8 1-12
38. K. Hao, H. Hanawa, L. Ding, Y. Ota, K. Yoshida, and K. Toba et al. Free heme is a danger signal inducing expression of proinflammatory proteins in cultured cells derived from normal rat hearts Mol Immunol 48 2011 1191 1202
39. A.S. Tsiftsoglou, A.I. Tsamadou, and L.C. Papadopoulou Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects Pharmacol Ther 111 2006 327 345 (Pubitemid 43832008)
40. S. Lin, Q. Yin, Q. Zhong, F.L. Lv, Y. Zhou, and J.Q. Li et al. Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage J Neuroinflammation 9 2012 46
41. C. Lisk, D. Kominsky, S. Ehrentraut, J. Bonaventura, R. Nuss, and K. Hassell et al. Hemoglobin-induced endothelial cell permeability is controlled, in-part, via an MyD88-dependent signaling mechanism Am J Respir Cell Mol Biol 49 2013 619 626
42. H. Akiyoshi, and T. Terada Centrilobular and perisinusoidal fibrosis in experimental congestive liver in the rat J Hepatol 30 1999 433 439 (Pubitemid 29113232)
43. H. Kitani, T. Takenouchi, M. Sato, M. Yoshioka, and N. Yamanaka A simple and efficient method to isolate macrophages from mixed primary cultures of adult liver cells J Vis Exp 51 2011 e2757
44. K.J. Moore, J. El Khoury, L.A. Medeiros, K. Terada, C. Geula, and A.D. Luster et al. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid J Biol Chem 277 2002 47373 47379 (Pubitemid 36163374)
45. H. Liu, H. Hanawa, T. Yoshida, R. Elnaggar, M. Hayashi, and R. Watanabe et al. Effect of hydrodynamics-based gene delivery of plasmid DNA encoding interleukin-1 receptor antagonist-Ig for treatment of rat autoimmune myocarditis: possible mechanism for lymphocytes and noncardiac cells Circulation 111 2005 1593 1600 (Pubitemid 40525158)
46. H. Chang, H. Hanawa, H. Liu, T. Yoshida, M. Hayashi, and R. Watanabe et al. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats J Immunol 177 2006 3635 3643 (Pubitemid 44359895)
47. S.R. Pasricha, Z. McQuilten, M. Westerman, A. Keller, E. Nemeth, and T. Ganz et al. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors Haematologica 96 2011 1099 1105
48. K.E. Finberg Unraveling mechanisms regulating systemic iron homeostasis Hematology Am Soc Hematol Educ Program 2011 2011 532 537
49. R.T. Figueiredo, P.L. Fernandez, D.S. Mourao-Sa, B.N. Porto, F.F. Dutra, and L.S. Alves et al. Characterization of heme as activator of Toll-like receptor 4 J Biol Chem 282 2007 20221 20229 (Pubitemid 47100035)
50. J.S. Byun, Y.G. Suh, H.S. Yi, Y.S. Lee, and W.I. Jeong Activation of Toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice J Hepatol 58 2013 342 349
51. H.H. Tan, M.I. Fiel, Q. Sun, J. Guo, R.E. Gordon, and L.C. Chen et al. Kupffer cell activation by ambient air particulate matter exposure may exacerbate nonalcoholic fatty liver disease J Immunotoxicol 6 2009 266 275
52. X. Wang, R. Sun, H. Wei, and Z. Tian High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: interaction of gammadelta T cells with macrophages Hepatology 57 2013 373 384
53. A. Garatti, A. Canziani, E. Mossuto, P. Gagliardotto, F. Innocente, and L. Corain et al. Tricuspid valve replacement with mechanical prostheses: long-term results J Heart Valve Dis 19 2010 194 200
54. M.R. Kramer, S.E. Marshall, A. Tiroke, N.J. Lewiston, V.A. Starnes, and J. Theodore Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation J Heart Lung Transplant 10 1991 317 321
55. L. Steingold, and A.A. Roberts Laboratory diagnosis of gastrointestinal bleeding Gut 2 1961 75 81
56. R.J. Donnelly, A.N. Rahman, S.M. Manohitharajah, and D.A. Watson Anaemia with artificial heart-valves Lancet 2 1972 283
57. V. Divakaran, S. Mehta, D. Yao, S. Hassan, S. Simpson, and E. Wiegerinck et al. Hepcidin in anemia of chronic heart failure Am J Hematol 86 2011 107 109
58. C.J. Rhodes, L.S. Howard, M. Busbridge, D. Ashby, E. Kondili, and J.S. Gibbs et al. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights J Am Coll Cardiol 58 2011 300 309
59. H.S. Choi, S.H. Song, J.H. Lee, H.J. Kim, and H.R. Yang Serum hepcidin levels and iron parameters in children with iron deficiency Korean J Hematol 47 2012 286 292
60. F. Artunc, and T. Risler Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease Nephrol Dial Transplant 22 2007 2900 2908 (Pubitemid 350093434) Technology